KLINGENSTEIN PAUL H 4
4 · Clovis Oncology, Inc. · Filed Jun 5, 2020
Insider Transaction Report
Form 4
KLINGENSTEIN PAUL H
Director
Transactions
- Award
Stock Option (right to buy)
2020-06-04+40,138→ 40,138 totalExercise: $6.48Exp: 2030-06-04→ Common Stock (40,138 underlying)
Footnotes (1)
- [F1]One-twelfth (1/12) of the shares subject to the option shall vest on each of the first twelve (12) monthly anniversaries of the date of grant.